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Conclusions: ESE-1b functions to regulate the expression of matrix pro-
teinases and IL-1β in articular cartilage. Thus, this transcription factor might
be potentially involved in slowing down disease progression of chronic
arthritides by suppressing proteinases and IL-1β expression.
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IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED GENES
FOLLOWING EXPOSURE OF HUMAN ARTICULAR CHONDROCYTES TO
HYPEROSMOTIC CONDITIONS
S.R. Tew, P.D. Clegg
Univ. of Liverpool, Liverpool, United Kingdom
Purpose: A number of physiochemical stimuli are thought to be important
for regulation of chondrocyte function. One of the most widely studied
is extracellular osmolarity which is thought to be altered as water is
expelled from articular cartilage during loading. A number of studies have
demonstrated that chondrocyte extracellular matrix (ECM) synthesis can be
regulated by changes in the osmotic environment. We previously demon-
strated that human articular chondrocytes (HAC) grown in hyperosmotic
conditions increase the expression of the transcription factor SOX9, a
key regulator of cartilage ECM genes, by stabilizing its mRNA. We were
interested in whether other genes were controlled in a similar manner
and so conducted a microarray screen to examine genes regulated by
hyperosmolarity. Then, using in silico and in vitro approaches, we identiﬁed
genes which were regulated post transcriptionally.
Methods: Human articular cartilage was obtained with informed consent
from patients undergoing knee replacement operations for osteoarthritis.
HAC were isolated by collagenase digestion, plated at 100,000 cells/cm2
and used in experiments within 24 hours. Cells from four donors were
used to perform microarray experiments and a further two for mRNA
decay studies. For microarray analysis the cells were initially grown in
serum free media adjusted to 380mOsm by addition of NaCl for 2 hours.
The media was then replaced with more 380mOsm media (controls) or
media adjusted to 550mOsm (hyperosmotic) and the cells were cultured
for a further 5 hours. Total RNA was then extracted from the HAC cultures
using Tri Reagent and sent to The Genome Centre, Queen Mary University
London where the samples were processed and used to probe an Illumina
Human Ref8 v.3.0 array. Genes increased by hyperosmolarity by an average
of 2-fold across all four donors were subjected to further analysis. The
presence of potential AU-rich elements (AREs) in the 3‘UTR of regulated
genes was determined by searching the AU-rich element database (ARED
- http://brp.kfshrc.edu.sa/ARED/). Real time PCR analysis was performed to
examine mRNA decay in actinomycin-D chase experiments which were
conducted on HAC under control or hyperosmotic conditions.
Results: Principal components analysis of microarray data revealed that
the major variation was caused by the difference in osmolarity between
cultures. 88 genes were upregulated >2-fold and 51 genes were down-
regulated >2 fold by hyperosmotic conditions. We focused on upregulated
genes in order to ﬁnd candidates that may have undergone mRNA stabiliza-
tion. Interrogation of the ARED database showed an overrepresentation of
ARE’s in the genes strongly upregulated by hyperosmolarity. Overall, 32% of
hyperosmotically regulated genes contained predicted ARE’s compared to a
genome wide value of less than 7%. The largest subset of ARE’s belonged to
the ARED deﬁned cluster type 5. RNA decay analysis of a number of these
genes showed that they demonstrated short mRNA half lives (min 1 hour
max 7.4 hours, average 3.2 hours) in HAC under control conditions. Fur-
thermore in 9 out of 15 cases, hyperosmotic culture conditions stabilized
the mRNA of these genes.
Conclusions: Recent microRNA research has underlined the importance of
post transcriptional control to gene regulation. Building on previous work
on post transcriptional control of SOX9 mRNA we have now described sim-
ilar regulation of a diverse set of genes. By combining microarray analysis
with in silico interrogation of the ARED database we have been able to
rapidly identify many genes which are post transcriptionally regulated in
HAC following exposure to hyperosmotic conditions. These genes have a
broad range of functions but all harbor ARE’s in their 3‘UTRs indicating
that common molecular mechanisms may be acting on these elements. It is
not clear whether these responses are limited to hyperosmotic stimulation
and further analysis of the stimuli and mechanisms involved is warranted.
An understanding of post transcriptional gene control by chondrocytes will
improve our appreciation how chondrocytes maintain cartilage homeosta-
sis and could result in identiﬁcation of therapeutic targets for treating joint
diseases.
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Purpose: Antero-medial gonarthrosis (AMG) is a distinct phenotype of knee
osteoarthritis (OA) that displays a constant and repeatable spatial pattern
of disease.
There is evidence from the literature supported by our own work for type
I collagen immunohistochemical staining in chondrocyte clusters and their
territorial matrix at the surface of damaged cartilage regions.
The aim was to quantitatively assess regional differences in type I and type
II collagen in cartilage from knees with AMG and aged, non-osteoarthritic
controls
Methods: Ten medial tibial joint resection specimens obtained from pa-
tients undergoing partial knee replacement were examined (mean age =
67 years). Full thickness cartilage was harvested from deﬁned zones: N
(macroscopically preserved cartilage) and T1, T2, and T3 (partial thickness
cartilage damage).
Sixteen equivalent control specimens were harvested from patients under-
going above knee amputation for peripheral vascular disease (mean age =
76 years). Only knees with no macroscopic evidence of osteoarthritis were
included. Control specimens were grouped according to histological grade
(modiﬁed Mankin score): 8 low-grade (score 3, “early OA group”). Cartilage
was harvested from equivalent zones. All samples were prepared using
optimised protocols for immunoassay for collagen type I and type II, and
quantitative real-time polymerase chain reaction (qrt-PCR) for the genes
COL1A1 and COL2A1.
The immunoassay used speciﬁc antibodies that have been validated and
published in the literature. The collagen content in micrograms is ex-
pressed as a percentage of sample dry weight. GAPDH was used as the
endogenous reference gene for qrt-PCR. Non-parametric tests were used
for statistical analysis of the results (Prism 5, Graphpad Software Inc.):
the Kruskal-Wallis test (post-hoc Dunn’s test) for the immunoassay; the
Wilcoxon signed ranked test for qrt-PCR. Statistical signiﬁcance was set at
p=0.05.
Results: Immunoassay: Type II collagen content (∼50% of dry weight) was
not signiﬁcantly different between cartilage zones in AMG, low-grade or
high-grade control specimens (p=0.375). There was no signiﬁcant different
between AMG and control specimens. Type I collagen content showed a
signiﬁcant regional difference in AMG (p=0.001) and high-grade control
specimens (p=0.015). The median type I collagen content was ∼1% of dry
weight in the damaged zones (T1, T2 & T3) and ∼4.5% of dry weight in the
preserved cartilage (N) for both AMG and high-grade controls. There was
Figure 1
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no such regional difference in type I collagen content in low-grade control
specimens (p=0.181).
Real-time PCR: COL2A1 expression was not signiﬁcantly different in regions
of damaged and preserved cartilage in AMG (p=0.156), low-grade control
(p=0.625) or high-grade control specimens (p=0.813). COL1A1 expression
in AMG specimens was signiﬁcantly greater in the preserved cartilage than
damaged cartilage (p=0.031). However, the regional difference in type I
collagen expression was not seen in low-grade (p=0.625) or high-grade
controls (p=0.219).
Conclusions: Type I collagen is abundant in ﬁbro-cartilage but only found
in very low levels in mature hyaline cartilage and is not usually found
in articular cartilage. Macroscopically normal cartilage in AMG exhibits
increased COL1A1 gene expression and a subsequent increase in type I
collagen matrix content. Type I collagen is also increased in the equivalent
region of knees with early histological features of OA
These ﬁndings suggest that these cartilage matrix and chondrocyte pheno-
type changes may be an early feature of OA change in AMG.
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Purpose: Previous studies have suggested that TWEAK may have an
important role in stimulating bone and cartilage destruction in various
arthritidies. The aim of this study was to investigate TWEAK and TWEAK
receptor (Fn14) expression in the cartilage and synovial tissues from os-
teoarthritic and normal (healthy) individuals. Protein expression of TWEAK
and TWEAK receptors (Fn14) was determined in cartilage from samples of
various grades of osteoarthritis (OA) and synovial tissue from patients with
OA and normal controls. TWEAK and Fn14 gene expression was studied in
various grades of OA cartilage. In addition, levels of soluble TWEAK present
in OA synovial ﬂuid were measured.
Methods: Synovial tissues from total of 10 OA and 10 normal subjects were
studied for TWEAK and Fn14 using immunohistochemistry. Osteoarthritic
cartilage was obtained from 21 patients undergoing primary hip replace-
ment and stained for TWEAK and Fn14 expression. Staining was assessed
using a standard semi-quantitative assessment carried out by two inde-
pendent observers. In addition, mRNA levels of TWEAK and Fn14 were
determined by real time RT PCR in the various grades of cartilage tissue.
TWEAK levels were measured in 15 OA synovial ﬂuid samples using a
commercial ELISA kit.
Results: Signiﬁcantly higher TWEAK (Figure 1A and B) and Fn14 was
detected in OA synovial tissue compared to the normal synovial tissue
(p<0.05) and expression was predominantly in the synovial lining.
In OA cartilage, the majority (18/21) all grades of samples expressed
TWEAK protein at low levels, whereas all samples (OA and normal) ex-
pressed high levels of Fn14 (Figure 1C and D). TWEAK and Fn14 mRNA was
more abundant in OA patients (Figure 2) with grade 2 cartilage damage
compared to those without any cartilage damage (p<0.05). TWEAK was
present in all OA synovial ﬂuids tested at a mean concentration of 713±134
pg/ml.
Figure 1. Synovial tissue expression of TWEAK (red stain) in OA and normal (B) tissues.
Cartilage tissue expression of Fn14 (red stain) in grade 2 (C) and grade 0 (D) tissues.
Conclusions: Previous studies have shown that TWEAK can induce met-
alloproteinase production in vitro by human chondrocytes and in murine
Figure 2. TWEAK and Fn14 mRNA in various grades of OA cartilage.
intervertebral disc tissues. As yet no studies have directly investigated the
presence of TWEAK and its receptor (FN14) in human OA tissues. The high
expression of Fn14 by chondrocytes in OA cartilage indicates that these
cells are able to respond to TWEAK. In OA tissues TWEAK was expressed
by chondrocytes in cartilage and highly expressed in the adjacent synovial
tissues. This is consistent with TWEAK protein in the OA synovial ﬂuid.
Overall the study indicates that TWEAK released from the synovial tissue
and chondrocytes in OA has a role in cartilage degradation.
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Purpose: Recent evidence has indicated a relationship between osteoarthri-
tis and altered glycosylation of cartilage and chondrocytes. Although the
glycobiology of cells is known to affect adhesion, receptor activity or
apoptosis, little information exists on the N- or O-glycome of human chon-
drocytes and on their signiﬁcance for the functionality of cartilage tissue. In
part, this fact may result from the methodological challenges encountered
with low glycosyltransferase transcription levels and linkage-type speciﬁc
glycoprotein glycan analysis. This study aimed to elucidate the glycome
of cultured human chondrocytes using a combination of RT-qPCR and
structural glycan analysis (LC-ESI-MS) and to deﬁne alterations of cellular
glycans upon treatment of chondrocytes with pro-inﬂammatory cytokines.
Methods: Primary chondrocytes were isolated from human OA cartilage
(n=8). Primary cells, SW1353 and C-28/I2 chondrocytes were cultured
in DMEM with 10% FCS or 1% ITS. 10 ng/ml IL-1β or 40 ng/ml TNF-α
were added as a pro-inﬂammatory stimulus. SYBR green based RT-qPCR
assays for 19 glycosyltransferases and 5 galectins were established using
GAPDH as reference. N- and O-glycan isolation was performed by PNGase
(N-glycans) or sodium hydroxide (O-Glycan) digestion prior to structural
identiﬁcation by LC-ESI-MS using Porous Graphitized Carbon as stationary
phase.
Results: About 100 different N- and O-glycans were detected and quan-
tiﬁed in human chondrocytes in the presence or absence of FCS. Major
N-glycans were found as sialylated diantennary structures, oligomannosidic
or hybrid-type glycans. The isomers of diantennary and oligomannosidic
N-glycans were fully assigned. Some structures were sulfated, contained
GalNAc or Lewis fucose residues, whereas tri and tetraantennary glycans
were present only to a minor extent. O-glycosylation mainly constituted of
core-1 and core-2 structures bearing one or two α2,3 linked sialic acids.
Primary chondrocytes predominantly expressed α2,6-speciﬁc sialyltrans-
ferases (SiaT) and α2,6-linked sialic acid residues in glycoprotein N-glycans.
In contrast, the preponderance of α2,3-linked sialyl residues and reduced
levels of α2,6-speciﬁc SiaT were associated with the altered chondrocyte
phenotype of C-28/I2 and SW1353 cells. Importantly, we found that both
IL-1β and TNF-α increased overall sialylation of N- and O-glycans and
induced a shift towards α2,3-linked sialic acid residues in primary chon-
drocyte glycoproteins. These results were supported by RT-qPCR showing
increased expression of α2,3 SiaT in treated cells. Moreover, we found
that both cytokines induced a considerable shift from oligomannosidic
glycans towards complex-type N-glycans, whereas core α1,6-fucosylation
was found to be reduced particularly by TNF-α.
